Edgewise Therapeutics, Inc. (EWTX)
Nasdaq: EWTX · Pharmaceutical Preparations · Boulder, CO · filing with the SEC since 2019
Who runs Edgewise Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Koch Kevin
President and CEO. First filing Mar 2021, latest Aug 14, 2026, 7 filings in all.
Officers reporting now
8
of 15 people with a filing in the last fifteen months
Directors reporting now
7
20 people on the record since 2021
Officerssales are open-market, Nov 10, 2025 to Nov 10, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Nofi Michael | Chief Financial Officer | Nov 2025 | Nov 10, 2026 | 1 · $200,000 |
| Derakhshan Behrad | Chief Business Officer | Mar 2021 | Aug 17, 2026 | 4 · $200,000 |
| Russell Alan J | Chief Scientific Officer | Mar 2021 | Aug 17, 2026 | 6 · $10.3M |
| Donovan Joanne M. | CMO | May 2021 | Aug 17, 2026 | 11 · $4.6M |
| Moore John R | General Counsel | Mar 2021 | Aug 17, 2026 | 4 · $200,000 |
| Koch Kevin | President and CEO | Mar 2021 | Aug 14, 2026 | 3 · $800,000 |
| Carruthers R Michael | Chief Financial Officer | Mar 2021 | Aug 14, 2025 | none |
| Blaustein Robert | Chief Development Officer | Jan 2025 | Aug 14, 2025 | none |
Directorssales are open-market, Nov 10, 2025 to Nov 10, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Fox Jonathan C | director | Mar 2023 | Oct 2, 2026 | none |
| Root Jonathan D | director | Mar 2021 | Jul 17, 2026 | none |
| Brege Laura | director | Mar 2021 | Jun 17, 2026 | none |
| Morris Arlene | director | May 2024 | Jun 17, 2026 | none |
| Thompson Peter A. | director | Mar 2021 | Jun 17, 2026 | none |
| Edris Badreddin | director | Mar 2021 | Jun 16, 2026 | 5 · $3.4M |
| Martin Christopher Nathan | director | Nov 2025 | Jun 16, 2026 | none |
Earlier names on the record11, newest filing first
Orbimed Advisors LLC · director · last filing Apr 2025Orbimed Capital Gp Vi LLC · director · last filing Apr 2025Orbimed Genesis Gp LLC · director · last filing Apr 2025Semigran Marc · officer · last filing Dec 2024Novo Holdings A/s · 10% owner · last filing Sep 2022Deerfield Management Company, L.P. (Series C) · 10% owner · last filing Mar 2021Deerfield Mgmt IV, L.P. · 10% owner · last filing Mar 2021Deerfield Private Design Fund IV, L.P. · 10% owner · last filing Mar 2021Flynn James E · 10% owner · last filing Mar 2021Wellington Biomedical Innovation Master Investors (Cayman) I L.P. · 10% owner · last filing Mar 2021Harrison Kenneth Ph.D. · director · last filing Mar 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.